Is NVMI a Buy or a Sell? The Bull and Bear Case (2026)

That depends on which case you find more convincing, and both are on this page. The bull case rests on Gate-all-around and the rising metrology intensity of leading-edge logic, with revenue (ttm) at ~$903M (trailing figure, before the record June quarter fully rolls in). The bear case rests on nova sells capital equipment into an industry that has historically swung hard in both directions, so a pause in leading-edge capex at any of the handful of customers that matter would show up in orders within a quarter or two, and the current multiple leaves little room for that. Analysts covering it are spread from $540.00 to $640.00, which is itself a signal that this is genuinely contested. If you believe the thesis, the real questions become sizing and overlap rather than timing. Walnut is not an investment adviser and this is not a recommendation.

Nobody can answer that for you, and the honest version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. Nova sells capital equipment into an industry that has historically swung hard in both directions, so a pause in leading-edge capex at any of the handful of customers that matter would show up in orders within a quarter or two, and the current multiple leaves little room for that. If that risk is what you were worried about and it is now playing out, that is a real signal. If the price simply fell while the thesis held, that is a different situation entirely. The most pessimistic published target is $540.00, +39.2% from the $387.97 price, which is one analyst's downside case rather than a floor. Walnut is not an investment adviser.

Gate-all-around and the rising metrology intensity of leading-edge logic. The industry's move from FinFET to gate-all-around transistors stacks nanosheet channels vertically, which creates buried structures that cannot be measured by looking at a wafer from above in the old way. The most optimistic analyst target on NVMI is $640.00, +65.0% from the $387.97 price. That figure is only reachable if this thesis works close to its best case.

Nova sells capital equipment into an industry that has historically swung hard in both directions, so a pause in leading-edge capex at any of the handful of customers that matter would show up in orders within a quarter or two, and the current multiple leaves little room for that. Concentration is real: four customers and three territories each represented at least 10% of product revenue, and China alone has been roughly 30% or more of the business even after declining from about 39%. That China exposure sits directly in the path of US, Dutch, and Japanese export controls plus tariff changes, none of which Nova controls. Operations, R&D, and a large share of manufacturing are concentrated in Israel, which carries geopolitical, mobilization, and logistics risk that the company itself flags at length in its 20-F. Competitively, KLA is far larger and holds the dominant share of metrology and inspection overall, while Onto Innovation and Camtek are pushing hard on the same advanced-packaging demand Nova is winning today, so share gains are not guaranteed to continue. Finally, the $750M convertible notes become dilutive to share count if the stock trades above the conversion price, and the shares have already traveled from roughly $233 to roughly $616 in a single year, which tells you how quickly sentiment on this name reprices. The most pessimistic published target is $540.00, +39.2% from the current price, which is roughly what the stock is worth if these risks bite rather than the drivers.

Nova Ltd. makes the optical and x-ray metrology systems chipmakers use to measure structures and materials during semiconductor manufacturing.

Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (Gate-all-around and the rising metrology intensity of leading-edge logic) stalling in the reported numbers rather than in the narrative, the risk above (nova sells capital equipment into an industry that has historically swung hard in both directions, so a pause in leading-edge capex at any of the handful of customers that matter would show up in orders within a quarter or two, and the current multiple leaves little room for that) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.

Systems that measure structures on a semiconductor wafer while it is still in production. Nova's optical tools use scatterometry to infer critical dimensions and film thickness from how light reflects off patterned structures, its x-ray tools measure material composition, and its chemical metrology line measures plating and process chemistry. Some tools are standalone units in the fab; others are integrated modules attached directly to another vendor's process equipment so measurement happens without moving the wafer.

No, and the distinction explains Nova's competitive position. Inspection looks for defects: particles, scratches, pattern breaks. Metrology measures: how wide is this line, how thick is this film, what is this layer made of. KLA dominates inspection and is also the largest metrology vendor, while Nova has concentrated on optical critical-dimension and materials metrology, where it is the second-largest player. Camtek and Onto Innovation straddle both categories, particularly in advanced packaging.

Nova has an ordinary NASDAQ listing under NVMI and is dual-listed on the Tel Aviv Stock Exchange under the same ticker. It is not an ADR, so US investors buy ordinary shares directly through any standard brokerage account. Nova files with the SEC as a foreign private issuer, which means an annual 20-F rather than a 10-K and 6-K filings rather than 8-Ks, so the disclosure cadence differs slightly from a US domestic filer.